Immune Score Based Radiomics in Nasopharyngeal Carcinoma (IMRAN Study)
Status: Recruiting
Location: See all (5) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
In nasopharyngeal carcinoma (NPC), tumor, node and metastasis (TNM) staging system is the main tool for determining treatment strategy and assessment of prognosis. However, the prognoses of patients with the same TNM stage after similar treatment vary widely. The aim of this study is to establish an immune score based radiomic staging system for NPC.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• Patients with newly histologically confirmed non-keratinizing/keratinizing carcinoma.
• ECOG Performance status: 0-1 With normal liver function test (ALT, AST ≤2.5ULN) Renal: creatinine clearance ≥60ml/min Without hematopathy,marrow: WBC \>4\*109/L, HGB\>90G/L, and PLT\>100\*109/L. Written informed consent
Locations
Other Locations
China
Zhejiang Cancer Hospital
RECRUITING
Hangzhou
Ningbo First Hospital
RECRUITING
Ningbo
Ningbo Medical Center Lihuili Hospital
RECRUITING
Ningbo
The First Affiliated Hospital of Wenzhou Medical University
RECRUITING
Wenzhou
Renmin Hospital of Wuhan University
RECRUITING
Wuhan
Contact Information
Primary
Xiaozhong Chen
cxzfyun@sina.com
0571-88128202
Time Frame
Start Date: 2021-11-05
Estimated Completion Date: 2027-12
Participants
Target number of participants: 494
Related Therapeutic Areas
Sponsors
Leads: Zhejiang Cancer Hospital
Collaborators: First Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Renmin Hospital of Wuhan University, Ningbo No. 1 Hospital